Intra-Cellular Therapies
ITCI
#1813
Rank
HK$70.50 B
Marketcap
HK$665.06
Share price
-0.22%
Change (1 day)
45.82%
Change (1 year)

Intra-Cellular Therapies (ITCI) Fails to deliver data

Key failure to deliver metrics for Intra-Cellular Therapies:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Intra-Cellular Therapies (ITCI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Intra-Cellular Therapies (ITCI) - since 2014

Volume in USD (price x number of shares), data since 2014

Intra-Cellular Therapies (ITCI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024HK$4.42 M-89.5%
2023HK$42.15 M51.56%
2022HK$27.81 M16.21%
2021HK$23.93 M25.98%
2020HK$18.99 M-33.46%
2019HK$28.54 M2213.17%
2018HK$1.23 M-95.97%
2017HK$30.59 M29.42%
2016HK$23.63 M-65.91%
2015HK$69.33 M104.09%
2014HK$33.97 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
HK$0.02 MHK$0.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.19 MHK$1.32 M๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0 MHK$2.21 M๐Ÿ‡บ๐Ÿ‡ธ USA